GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Study Develops Fe3O4@Cg-DTC/AgNPs Composite for Antimicrobial and Anti-Biofilm Applications

by GOAI
Share To

A recent study detailed the development of a novel antimicrobial and anti-biofilm agent through a layer-by-layer preparation method. Researchers synthesized Fe3O4@Cg-DTC/AgNPs, a composite material combining magnetic nanoparticles (Fe3O4), carbon dots (Cg), dithiocarbamate (DTC), and silver nanoparticles (AgNPs). The study focused on the material’s potential applications in combating microbial infections and biofilm formation.

The research outlined the step-by-step synthesis process, which involved coating Fe3O4 nanoparticles with carbon dots, followed by functionalization with dithiocarbamate and subsequent incorporation of silver nanoparticles. The resulting composite demonstrated significant antimicrobial properties against various microorganisms. Additionally, it showed effectiveness in preventing biofilm formation, which is often associated with persistent infections and antibiotic resistance. The findings suggest that this material could serve as a promising tool for addressing challenges related to microbial contamination and biofilm-associated issues.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top